Personensuche
Personensuche
Es wurde 1 Person gefunden.
Funktionen
-
Assistenzarzt/-ärztin, Klinik für Dermatologie
Aktuelle Veranstaltungen
-
2024 WS
Vergangene Veranstaltungen (max. 10)
-
2024 SS
-
2023 WS
-
2023 SS
-
2022 WS
-
2022 SS
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanomaIn: Frontiers in Immunology Jg. 15 (2024) 1383125Online Volltext: dx.doi.org/ (Open Access)
-
Deep learning based histological classification of adnex tumorsIn: European Journal of Cancer (EJC) Jg. 196 (2024) 113431Online Volltext: dx.doi.org/
-
Early versus late response to PD-1-based immunotherapy in metastatic melanomaIn: European Journal of Cancer (EJC) Jg. 210 (2024) 114295Online Volltext: dx.doi.org/ (Open Access)
-
S1-Guideline Sebaceous CarcinomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 22 (2024) Nr. 5, S. 730 - 747Online Volltext: dx.doi.org/ (Open Access)
-
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- (“Triple”) wild type melanomasIn: European Journal of Cancer (EJC) Jg. 208 (2024) 114208Online Volltext: dx.doi.org/ (Open Access)
-
Applying an artificial intelligence deep learning approach to routine dermatopathological diagnosis of basal cell carcinomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. 11, S. 1329 - 1337Online Volltext: dx.doi.org/
-
Characterisation and outcome of RAC1 mutated melanomaIn: European Journal of Cancer (EJC) Jg. 183 (2023) S. 1 - 10Online Volltext: dx.doi.org/
-
Clinical practice guidelines for the diagnosis and surveillance of BAP1 tumour predisposition syndromeIn: European Journal of Human Genetics Jg. 31 (2023) Nr. 11, S. 1261 - 1269Online Volltext: dx.doi.org/ (Open Access)
-
Clinical, histopathological and molecular features of dedifferentiated melanomas : An EORTC Melanoma Group Retrospective AnalysisIn: European Journal of Cancer (EJC) Jg. 187 (2023) S. 7 - 14Online Volltext: dx.doi.org/ (Open Access)
-
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma ADOREG/TRIM : Analysis of the DeCOG prospective multicenter cohort studyIn: EBioMedicine Jg. 96 (2023) 104774Online Volltext: dx.doi.org/ (Open Access)
-
Deep learning detection of melanoma metastases in lymph nodesIn: European Journal of Cancer (EJC) Jg. 188 (2023) S. 161 - 170Online Volltext: dx.doi.org/
-
HLA class II loss and JAK1/2 deficiency coevolve in melanoma leading to CD4 T cell and IFNγ cross-resistanceIn: Clinical Cancer Research Jg. 29 (2023) Nr. 15, S. 2894 - 2907Online Volltext: dx.doi.org/
-
Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive CancersIn: Cancer Discovery Jg. 13 (2023) Nr. 1, S. 70 - 84Online Volltext: dx.doi.org/ (Open Access)
-
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma : a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREGIn: European Journal of Cancer (EJC) Jg. 188 (2023) S. 140 - 151Online Volltext: dx.doi.org/
-
Checkpoint immunotherapy of cutaneous squamous cell carcinoma in patients suffering from chronic lymphocytic leukaemia : divergent outcomes in two men treated with PD-1 inhibitorsIn: Journal of the European Academy of Dermatology and Venereology Jg. 36 (2022) Nr. S1: Anti PD-1 Therapy of Advanced Cutaneous Squamous Cell Carcinoma, S. 41 - 44Online Volltext: dx.doi.org/ (Open Access)
-
Circulating cell‐free messenger RNA enables non‐invasive pan‐tumour monitoring of melanoma therapy independent of the mutational genotypeIn: Clinical and Translational Medicine Jg. 12 (2022) Nr. 11, e1090Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Clinical and pathological characteristics of familial melanoma with germline TERT promoter variantsIn: Pigment Cell and Melanoma Research Jg. 35 (2022) Nr. 6, S. 573 - 586Online Volltext: dx.doi.org/ (Open Access)
-
Deep Learning Assisted Diagnosis of Onychomycosis on Whole-Slide ImagesIn: Journal of Fungi Jg. 8 (2022) Nr. 9, 912Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Evaluation of a Deep Learning Approach to Differentiate Bowen’s Disease and Seborrheic KeratosisIn: Cancers Jg. 14 (2022) Nr. 14, 3518Online Volltext: dx.doi.org/ (Open Access)
-
Genetic and Clinical Characteristics of ARID1A Mutated Melanoma Reveal High Tumor Mutational Load without Implications on Patient SurvivalIn: Cancers Jg. 14 (2022) Nr. 9, 2090Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Genetic and Methylation Analysis of CTNNB1 in Benign and Malignant Melanocytic LesionsIn: Cancers Jg. 14 (2022) Nr. 17, 4066Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Genetic and methylation profiles distinguish benign, malignant and spitzoid melanocytic tumorsIn: International Journal of Cancer Jg. 151 (2022) Nr. 9, S. 1542 - 1554Online Volltext: dx.doi.org/ (Open Access)
-
Genetic characterization of advanced conjunctival melanoma and response to systemic treatmentIn: European Journal of Cancer (EJC) Jg. 166 (2022) S. 60 - 72Online Volltext: dx.doi.org/
-
Giant congenital melanocytic naevus caused by NRAS Q61K mosaicismIn: JEADV Clinical Practice Jg. 1 (2022) Nr. 4, S. 416 - 419Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Management of partial and non-responding cutaneous squamous cell carcinomaIn: Journal of the European Academy of Dermatology and Venereology Jg. 36 (2022) Nr. S1, S. 29 - 34Online Volltext: dx.doi.org/ (Open Access)
-
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapyIn: European Journal of Cancer (EJC) Jg. 161 (2022) S. 99 - 107Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
The Prognostic Relevance of PMCA4 Expression in Melanoma : Gender Specificity and Implications for Immune Checkpoint InhibitionIn: International Journal of Molecular Sciences (IJMS) Jg. 23 (2022) Nr. 6, 3324Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 ImmunohistochemistryIn: Frontiers in Oncology Jg. 11 (2021) 725549Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Digital Quantification of Tumor PD-L1 Predicts Outcome of PD-1-Based Immune Checkpoint Therapy in Metastatic MelanomaIn: Frontiers in Oncology Jg. 11 (2021) 741993Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
GNA14, GNA11, and GNAQ Mutations Are Frequent in Benign but Not Malignant Cutaneous Vascular TumorsIn: Frontiers in Genetics Jg. 12 (2021) 663272Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
High-resolution three-dimensional imaging for precise staging in melanomaIn: European Journal of Cancer (EJC) Jg. 159 (2021) S. 182 - 193Online Volltext: dx.doi.org/ (Open Access)
-
Metastatic pigmented epithelioid melanocytoma in a 7-year-old femaleIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. 8, S. 1217 - 1219Online Volltext: dx.doi.org/ (Open Access)
-
Molecular pathology as a diagnostic aid in difficult-to-classify melanocytic tumours with spitzoid morphologyIn: European Journal of Cancer (EJC) Jg. 148 (2021) S. 340 - 347Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitorsIn: European Journal of Cancer (EJC) Jg. 159 (2021) S. 113 - 124Online Volltext: dx.doi.org/ (Open Access)
-
Rare TERT Promoter Mutations Present in Benign and Malignant Cutaneous Vascular TumorsIn: Dermato Jg. 1 (2021) Nr. 1, S. 18 - 25Online Volltext: dx.doi.org/ (Open Access)
-
Response to comment : Molecular pathology as a diagnostic aid in difficult to classify melanocytic tumours with spitzoid morphologyIn: European Journal of Cancer (EJC) Jg. 157 (2021) S. 514 - 515Online Volltext: dx.doi.org/
-
Sarcoma classification by DNA methylation profilingIn: Nature Communications Jg. 12 (2021) Nr. 1, S. 498Online Volltext: dx.doi.org/ (Open Access)
-
CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti–PD-L1 TreatmentIn: Cancer Immunology Research Jg. 8 (2020) Nr. 9, S. 1163 - 1179Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Deep Penetrating Nevus and Borderline-Deep Penetrating Nevus : A Literature ReviewIn: Frontiers in Oncology Jg. 10 (2020) S. 837Online Volltext: dx.doi.org/ (Open Access)
-
Fatal swelling of the groin – Clear cell sarcoma : A rare but important differential diagnosis to malignant melanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. 10, S. 1165 - 1168Online Volltext: dx.doi.org/ (Open Access)
-
GNAQ and GNA11 mutant nonuveal melanoma : A subtype distinct from both cutaneous and uveal melanomaIn: British Journal of Dermatology: BJD Jg. 183 (2020) Nr. 5, S. 928 - 939Online Volltext: dx.doi.org/ (Open Access)
-
Immuntherapie beim malignen MelanomIn: Der Internist Jg. 61 (2020) Nr. 7, S. 669 - 675Online Volltext: dx.doi.org/ (Open Access)
-
Malignes Melanom : Stellenwert der BRAF-Inhibition beim malignen MelanomIn: Der Onkologe Jg. 26 (2020) Nr. 8, S. 713 - 720Online Volltext: dx.doi.org/
-
Re: Deep learning outperformed 11 pathologists in the classification of histopathological melanoma imagesIn: European Journal of Cancer (EJC) Jg. 130 (2020) S. 259 - 261Online Volltext: dx.doi.org/ (Open Access)
-
Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapyIn: The Journal of Clinical Investigation (JCI) Jg. 130 (2020) Nr. 8, S. 4266 - 4281Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification taskIn: European Journal of Cancer (EJC) Jg. 111 (2019) S. 148 - 154Online Volltext: dx.doi.org/ (Open Access)
-
An Animal Model of Cutaneous Cyst Development Enables the Identification of Three Quantitative Trait Loci, Including the Homologue of a Human Locus (TRICY1)In: Journal of Investigative Dermatology Jg. 139 (2019) Nr. 10, S. 2235 - 2238.e5Online Volltext: dx.doi.org/ (Open Access)
-
Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanomaIn: JCO Precision Oncology Jg. 3 (2019)Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Assessment of Nonradioactive Multispectral Optoacoustic Tomographic Imaging With Conventional Lymphoscintigraphic Imaging for Sentinel Lymph Node Biopsy in MelanomaIn: JAMA Network Open Jg. 2 (2019) Nr. 8, S. e199020Online Volltext: dx.doi.org/ (Open Access)
-
Clinical and genetic analysis of melanomas arising in acral sitesIn: European Journal of Cancer (EJC) Jg. 119 (2019) S. 66 - 76Online Volltext: dx.doi.org/ (Open Access)
-
Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification taskIn: European Journal of Cancer (EJC) Jg. 113 (2019) S. 47 - 54Online Volltext: dx.doi.org/ (Open Access)
-
Digitales papilläres Adenokarzinom : Vier Fallberichte mit kurzer LiteraturübersichtIn: Der Hautarzt Jg. 70 (2019) Nr. 3, S. 204 - 209Online Volltext: dx.doi.org/
-
Frequent Occurrence of NRAS and BRAF Mutations in Human Acral NaeviIn: Cancers Jg. 11 (2019) Nr. 4, S. 546Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Genome-wide methylation profiling and copy number analysis in atypical fibroxanthomas and pleomorphic dermal sarcomas indicate a similar molecular phenotypeIn: Clinical Sarcoma Research Jg. 9 (2019) 2Online Volltext: dx.doi.org/ (Open Access)
-
Prognostic significance of NAB2–STAT6 fusion variants and TERT promotor mutations in solitary fibrous tumors/hemangiopericytomas of the CNS : not (yet) clearIn: Acta Neuropathologica Jg. 137 (2019) Nr. 4, S. 679 - 682Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Proton radiotherapy in advanced malignant melanoma of the conjunctivaIn: Graefes Archive for Clinical and Experimental Ophthalmology Jg. 257 (2019) Nr. 6, S. 1309 - 1318Online Volltext: dx.doi.org/
-
The X-Linked DDX3X RNA Helicase Dictates Translation Reprogramming and Metastasis in MelanomaIn: Cell Reports Jg. 27 (2019) Nr. 12, S. 3573 - 3586.e7Online Volltext: dx.doi.org/ (Open Access)
-
ctDNA as a noninvasive monitoring tool in metastatic melanomaIn: Journal of Clinical Oncology (JCO) Jg. 37 (2019) Nr. Suppl. 15, S. 9548Online Volltext: dx.doi.org/
-
Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profilesIn: Modern Pathology Jg. 31 (2018) Nr. 3, S. 418 - 428Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal MelanomaIn: Cell Reports Jg. 22 (2018) Nr. 9, S. 2455 - 2468Online Volltext: dx.doi.org/ (Open Access)
-
Integrated genomic classification of melanocytic tumors of the central nervous system using mutation analysis, copy number alterations, and DNA methylation profilingIn: Clinical Cancer Research Jg. 24 (2018) Nr. 18, S. 4494 - 4504Online Volltext: dx.doi.org/ (Open Access)
-
Intraventricular melanocytoma diagnosis confirmed by gene mutation profileIn: Neuropathology Jg. 38 (2018) Nr. 3, S. 288 - 292Online Volltext: dx.doi.org/
-
Konjunktivales Melanom : Standardisiertes Vorgehen in Diagnostik, Therapie und NachsorgeIn: Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft Jg. 115 (2018) Nr. 6, S. 489 - 498Online Volltext: dx.doi.org/
-
NF1 mutations in conjunctival melanomaIn: British Journal of Cancer (BJC) Jg. 118 (2018) Nr. 9, S. 1243 - 1247Online Volltext: dx.doi.org/ (Open Access)
-
Oxygenation Status in Chronic Leg Ulcer After Topical Hemoglobin Application May Act as a Surrogate Marker to Find the Best Treatment Strategy and to Avoid Ineffective Conservative Long-term TherapyIn: Molecular Imaging and Biology Jg. 20 (2018) Nr. 1, S. 124 - 130Online Volltext: dx.doi.org/
-
Re: van Poppelen et al.: Genetic background of iris melanomas and iris melanocytic tumors of uncertain malignant potential (Ophthalmology. 2018;125:904-912)In: Ophthalmology Jg. 125 (2018) Nr. 11, S. e78 - e79Online Volltext: dx.doi.org/ (Open Access)
-
The genetic basis for most patients with pustular skin disease remains elusiveIn: British Journal of Dermatology: BJD Jg. 178 (2018) Nr. 3, S. 740 - 748Online Volltext: dx.doi.org/ (Open Access)
-
Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy ResistanceIn: Journal of the National Cancer Institute (JNCI) Jg. 110 (2018) Nr. 6, S. 677 - 681Online Volltext: dx.doi.org/ (Open Access)
-
Acquired IFNγ 3 resistance impairs anti-Tumor immunity and gives rise to T-cell-resistant melanoma lesionsIn: Nature Communications Jg. 8 (2017) 15440Online Volltext: dx.doi.org/ (Open Access)
-
Activating CYSLTR2 and PLCB4 Mutations in Primary Leptomeningeal Melanocytic TumorsIn: Journal of Investigative Dermatology Jg. 137 (2017) Nr. 9, S. 2033 - 2035Online Volltext: dx.doi.org/
-
Activating cysteinyl leukotriene receptor 2 (CYSLTR2) mutations in blue neviIn: Modern Pathology Jg. 30 (2017) Nr. 3, S. 350 - 356Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Epidermal growth factor receptor gaining impact in cutaneous squamous cell carcinomaIn: British Journal of Dermatology: BJD Jg. 176 (2017) Nr. 5, S. 1126 - 1127Online Volltext: dx.doi.org/
-
Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris MelanomaIn: Investigative Ophthalmology & Visual Science, IOVS Jg. 58 (2017) Nr. 9, S. 3464 - 3470Online Volltext: dx.doi.org/ (Open Access)
-
Integrative analysis identifies four molecular and clinical subsets in uveal melanomaIn: Cancer Cell Jg. 32 (2017) Nr. 2, S. 204 - 220.e15Online Volltext: dx.doi.org/ (Open Access)
-
Melanoma diagnosed in lesions previously treated by laser therapyIn: The Journal of Dermatology Jg. 44 (2017) Nr. 1, S. 23 - 28Online Volltext: dx.doi.org/
-
Next-Generation Sequencing to Guide Treatment of Advanced MelanomaIn: American Journal of Clinical Dermatology Jg. 18 (2017) Nr. 3, S. 303 - 310Online Volltext: dx.doi.org/
-
Role of mutational status of GNAQ and GNA11 in the diagnosis of melanocytic tumors : ResponseIn: Journal of Neurosurgery (JNS) Jg. 126 (2017) Nr. 3, S. 1024 - 1026Online Volltext: dx.doi.org/
-
SF3B1 and BAP1 mutations in blue nevus-like melanomaIn: Modern Pathology Jg. 30 (2017) Nr. 7, S. 928 - 939Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Targeted next generation sequencing of mucosal melanomas identifies frequent NF1 and RAS mutationsIn: OncoTarget Jg. 8 (2017) Nr. 25, S. 40683 - 40692Online Volltext: dx.doi.org/ (Open Access)
-
Biomarkers in melanomaIn: Scandinavian Journal of Clinical and Laboratory Investigation Jg. 76 (2016) Nr. Suppl. 245, S. S104 - S112Online Volltext: dx.doi.org/
-
Diagnosing a Primary Leptomeningeal Melanoma by Gene Mutation SignatureIn: Journal of Investigative Dermatology Jg. 136 (2016) Nr. 7, S. 1526 - 1528Online Volltext: dx.doi.org/
-
High TERT promoter mutation frequency in non-acral cutaneous metastatic melanomaIn: Pigment Cell and Melanoma Research Jg. 29 (2016) Nr. 5, S. 598 - 600Online Volltext: dx.doi.org/
-
Melanoma Lesions Independently Acquire T-cell Resistance during Metastatic LatencyIn: Cancer Research Jg. 76 (2016) Nr. 15, S. 4347 - 4358Online Volltext: dx.doi.org/
-
Molekulare und immunhistochemische Diagnostik beim MelanomIn: Der Hautarzt Jg. 67 (2016) Nr. 7, S. 511 - 518Online Volltext: dx.doi.org/
-
Oncogene status as a diagnostic tool in ocular and cutaneous melanomaIn: European Journal of Cancer (EJC) Jg. 57 (2016) S. 112 - 117Online Volltext: dx.doi.org/
-
Single-strand DNA library preparation improves sequencing of formalin-fixed and paraffin-embedded (FFPE) cancer DNAIn: OncoTarget Jg. 7 (2016) Nr. 37, S. 59115 - 59128Online Volltext: dx.doi.org/ (Open Access)
-
Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous systemIn: Journal of Neuro-Oncology Jg. 127 (2016) Nr. 3, S. 435 - 444Online Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Analysis of SDHD promoter mutations in various types of melanomaIn: OncoTarget Jg. 6 (2015) Nr. 28, S. 25868 - 25882Online Volltext: dx.doi.org/ (Open Access)
-
Analysis of SDHD promoter mutations in various types of melanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 13 (2015) Nr. Suppl. 2, S. 11Online Volltext: dx.doi.org/
-
Corticosteroids Augment BRAF Inhibitor Vemurafenib Induced Lymphopenia and Risk of InfectionIn: PLoS ONE Jg. 10 (2015) Nr. 4, S. e0124590Online Volltext: dx.doi.org/ (Open Access)
-
Die multispektraloptoakustische Tomographie (MSOT) zur nichtinvasiven Diagnostik des Schildwächterlymphknotens bei Patienten mit malignem MelanomIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 13 (2015) Nr. 12, S. 1323Online Volltext: dx.doi.org/
-
Frequent TERT Promoter Mutations in Ocular Surface Squamous NeoplasiaIn: Investigative Ophthalmology & Visual Science, IOVS Jg. 56 (2015) Nr. 10, S. 5854 - 5861Online Volltext: dx.doi.org/ (Open Access)
-
Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningiomaIn: Neuropathology Jg. 35 (2015) Nr. 1, S. 24 - 36Online Volltext: dx.doi.org/
-
Metastatic status of sentinel lymph nodes in melanoma determined noninvasively with multispectral optoacoustic imagingIn: Immunotherapy Jg. 7 (2015) Nr. 317, S. 317ra199Online Volltext: dx.doi.org/
-
Molekulare Diagnostik bei melanozytären TumorenIn: Der Pathologe Jg. 36 (2015) Nr. 1, S. 30 - 36Online Volltext: dx.doi.org/
-
Panel Sequencing MelanomasIn: Journal of Investigative Dermatology Jg. 135 (2015) Nr. 2, S. 335 - 336Online Volltext: dx.doi.org/ (Open Access)
-
Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal MelanomaIn: PLoS ONE Jg. 10 (2015) Nr. 3, S. e0118564Online Volltext: dx.doi.org/ (Open Access)
-
Reply to the letters to the editor ‘Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanoma’ by Diwakar et al.In: Annals of Oncology Jg. 26 (2015) Nr. 1, S. 250 - 251Online Volltext: dx.doi.org/
-
ResponseIn: Journal of the National Cancer Institute (JNCI) Jg. 107 (2015) Nr. 4, S. djv051Online Volltext: dx.doi.org/
-
Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathwayIn: OncoTarget Jg. 6 (2015) Nr. 34, S. 36041 - 36052Online Volltext: dx.doi.org/ (Open Access)
-
Absence of TERT promoter mutations in primary melanocytic tumours of the central nervous systemIn: Neuropathology and Applied Neurobiology Jg. 40 (2014) Nr. 6, S. 794 - 797Online Volltext: dx.doi.org/
-
Angioplasmacellular hyperplasia - a new histopathologic clue for anogenital herpes simplex recidivans in immunocompromised patients?In: American Journal of Dermatopathology Jg. 36 (2014) Nr. 10, S. 822 - 826Online Volltext: dx.doi.org/
-
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanomaIn: Annals of Oncology Jg. 25 (2014) Nr. 3, S. 747 - 753Online Volltext: dx.doi.org/
-
Genetic alterations and personalized medicine in melanoma: Progress and future prospectsIn: Journal of the National Cancer Institute (JNCI) Jg. 106 (2014) Nr. 2, S. djt435Online Volltext: dx.doi.org/
-
Genetic and clinico-pathologic analysis of metastatic uveal melanomaIn: Modern Pathology Jg. 27 (2014) Nr. 2, S. 175 - 183Online Volltext: dx.doi.org/
-
Genetic evolution of T-cell resistance in the course of melanoma progressionIn: Clinical Cancer Research Jg. 20 (2014) Nr. 24, S. 6593 - 6604Online Volltext: dx.doi.org/
-
Immune Modulating Effects of NKT Cells in a Physiologically Low Dose Leishmania major Infection Model after αGalCer Analog PBS57 StimulationIn: PLoS Neglected Tropical Diseases Jg. 8 (2014) Nr. 6, S. e2917Online Volltext: dx.doi.org/ (Open Access)
-
TERT promoter mutation status as an independent prognostic factor in cutaneous melanomaIn: Journal of the National Cancer Institute (JNCI) Jg. 106 (2014) Nr. 9,Online Volltext: dx.doi.org/
-
TERT promoter mutations are frequent in atypical fibroxanthomas and pleomorphic dermal sarcomasIn: Modern Pathology Jg. 27 (2014) Nr. 4, S. 502 - 508Online Volltext: dx.doi.org/ (Open Access)
-
Combination of BRAF inhibitors and brain radiotherapy in patients with metastatic melanoma shows minimal acute toxicityIn: Journal of Clinical Oncology (JCO) Jg. 31 (2013) Nr. 30, S. 3844 - 3845Online Volltext: dx.doi.org/
-
Conjunctival Melanomas Harbor BRAF and NRAS Mutations—ResponseIn: Clinical Cancer Research Jg. 19 (2013) Nr. 22, S. 6331 - 6332Online Volltext: dx.doi.org/
-
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomasIn: Clinical Cancer Research Jg. 19 (2013) Nr. 12, S. 3143 - 3152Online Volltext: dx.doi.org/
-
Kombination von BRAF-Inhibitoren (BRAFi) und zerebraler Bestrahlung bei Patienten mit metastasiertem Melanom : Eine mögliche Behandlungsoption für neu aufgetretene oder pro-grediente Hirnmetastasen unter Therapie mit BRAF-InhibitorenIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 11 (2013) Nr. 9, S. 952 - 952
-
Lack of SF3B1 R625 mutations in cutaneous melanomaIn: Diagnostic Pathology Jg. 8 (2013) S. 87Online Volltext: dx.doi.org/ (Open Access)
-
New developments in biomarkers for melanomaIn: Current Opinion in Oncology Jg. 25 (2013) Nr. 2, S. 145 - 151Online Volltext: dx.doi.org/
-
Pathology and genetics of uveal melanomaIn: Pathology Jg. 45 (2013) Nr. 1, S. 18 - 27Online Volltext: dx.doi.org/
-
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinomaIn: PLoS ONE Jg. 8 (2013) Nr. 11, S. e80354Online Volltext: dx.doi.org/ (Open Access)
-
TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumoursIn: British Journal of Cancer (BJC) Jg. 109 (2013) Nr. 2, S. 497 - 501Online Volltext: dx.doi.org/ (Open Access)
-
Tumor regression and sirolimus-based therapy in lung transplantationIn: The Journal of Heart and Lung Transplantation Jg. 32 (2013) Nr. 9, S. 938 - 939Online Volltext: dx.doi.org/
-
Vemurafenib reverses immunosuppression by myeloid derived suppressor cellsIn: Cancer Research Jg. 73 (2013) Nr. 8 Suppl., S. 4714Online Volltext: dx.doi.org/
-
Vemurafenib reverses immunosuppression by myeloid derived suppressor cellsIn: International Journal of Cancer Jg. 133 (2013) Nr. 7, S. 1653 - 1663Online Volltext: dx.doi.org/
-
Genetic and molecular characterization of uveal melanoma cell linesIn: Pigment Cell and Melanoma Research Jg. 25 (2012) Nr. 2, S. 182 - 187Online Volltext: dx.doi.org/
-
Außergewöhnlicher Therapiebenefit von Imatinib bei cKIT-mutiertem Schleimhautmelanom mit nachfolgendem KIT-Mutationsverlust
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21 - 22Online Volltext: dx.doi.org/ (Open Access) -
Die PD-L1-Expression im Tumor prognostiziert je nach Art des untersuchten Gewebes das Outcome einer Anti-PD-1-basierten Immuntherapie bei metastasiertem Melanom
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 27 - 28Online Volltext: dx.doi.org/ (Open Access) -
Etablierung eines Mustererkennungsalgorithmus zur histologischen Detektion von Melanommetastasen im Schildwächterlymphknoten
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 20 - 21Online Volltext: dx.doi.org/ (Open Access) -
Molekulare und klinische Charakterisierung von BRAF/NRAS/NF1-wt Melanomen
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 21Online Volltext: dx.doi.org/ (Open Access) -
Untersuchung des klinischen Verlaufs von Melanompatienten mit einer Super-Response (CR/PR innerhalb von 3 Monaten) unter PD-1-basierter Immuncheckpoint-Inhibition : eine Subgruppen-Analyse der prospektiven multizentrischen Studie ADOREG
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 8 - 9Online Volltext: dx.doi.org/ (Open Access) -
Etablierung eines Deep-Learning-Algorithmus zur Differenzierung von Morbus Bowen und seborrhoischen Keratosen
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 15Online Volltext: dx.doi.org/ -
Im Plasma zirkulierende zellfreie mRNA ermöglicht die minimal-invasive und Genotyp-unabhängige Therapieüberwachung bei Patienten mit Melanom
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 12 - 13Online Volltext: dx.doi.org/ -
Klinische und pathologische Merkmale des familiären Melanoms bei Keimbahn-TERT-Promotorvarianten
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 6Online Volltext: dx.doi.org/ -
Immune checkpoint-Inhibition in Patients with NRAS-mutated Melanoma compared to Patients with NRAS Wild-type Melanoma : Results of a Study on 702 Patients from the prospective, multicenter Registry ADOREGIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 59 - 60
-
Interferon-independent enhancement of melanoma cell immunogenicity by RIG-I activation
47th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) Virtual, March 04‐06, 2021,In: Experimental Dermatology Jg. 30 (2021) Nr. 3, S. E78 -
PD-L1-Expression and Mutation Profile in pre-therapeutic Tumor Tissue as Predictors of the Therapeutic Success of PD-1-based Immune Checkpoint Inhibition Therapy in Patients with metastatic Melanoma : Evaluation of the prospective multicentric ADO-Study TRIMIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 19
-
Predictors of Super-response (CR/PR within 3 Months) under PD-1-based Immune Checkpoint Inhibition in metastatic Melanoma : A Subgroup Analysis of the prospective multicenter Study ADOREG TRIMIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 6 - 7
-
TERT Promoter Mutations associated with longer progression-free and Overall Survival under BRAF/MEK TherapyIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 31
-
Tumor PD-L1 expression and gene panel mutational profile as outcome predictors of PD-1-based checkpoint inhibition therapy in metastatic melanoma : A prospective multicenter DeCOG studyIn: Journal of Clinical Oncology (JCO) Jg. 39 (2021) Nr. 15_Suppl, S. 9568 - 9568Online Volltext: dx.doi.org/
-
Tumor PD-L1-Positivity in medical and digital Quantification predicts a favorable Patient Outcome for a PD-1-based Immune Checkpoint-Blockade in metastatic MelanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 19 (2021) Nr. Suppl. 4, S. 58 - 59
-
Die digitale Analyse der Tumor PD‐L1 Expression ist ein guter Prädiktor des Therapieerfolgs einer anti‐PD1‐basierten Immuntherapie : Eine Subgruppenanalyse der multizentrischen translationalen Studie ADOREG/TRIMIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV36Online Volltext: dx.doi.org/ (Open Access)
-
Eindrucksvolles und schnelles Therapieansprechen eines metastasierten Adnexkarzinoms unter CemiplimabIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV08Online Volltext: dx.doi.org/ (Open Access)
-
RIG-I activation enhances melanoma immunogenicity and improves anti-tumor T cell responses in combination with anti-PD-1 immune checkpoint blocking antibodiesIn: Journal for ImmunoTherapy of Cancer Jg. 8 (2020) Nr. Suppl. 2, S. A3Online Volltext: dx.doi.org/ (Open Access)
-
Tumorzell‐intrinsiche Aktivierung des Immunrezeptors RIG‐I in Kombination mit Immun‐Checkpoint‐Blockade verbessert anti‐Tumor T‐ZellantwortenIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 18 (2020) Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. FV18Online Volltext: dx.doi.org/ (Open Access)
-
Clear Cell Sarcoma - a rare Differential Diagnosis of malignant MelanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. Suppl. 6, S. 3
-
Die Anzahl mutierter Melanom‐assoziierter Gene und die Expression von PD‐L1 sind unabhängige Prädiktoren der anti‐PD1 Immuntherapie ‐ eine prospektive Registerstudie der ADO (ADOREG/TRIM)In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 7 - 8Online Volltext: dx.doi.org/ (Open Access)
-
Klarzellsarkom – eine seltene Differentialdiagnose des malignen Melanoms
28. Deutschen Hautkrebskongresses (ADO‐Jahrestagung); 13.–15. September 2018; Stuttgart,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 16 (2018) Nr. S6, S. 3Online Volltext: dx.doi.org/ (Open Access) -
Oncogene and copy number analysis of a larger cohort of conjunctival melanomaIn: Experimental Dermatology Jg. 22 (2013) Nr. 3, S. E43
-
Die Aufdeckung genetischer Alterationen bei kutanen und okularen NeoplasienDuisburg, Essen (2014) 1 CD-ROM
-
High-resolution 3-D imaging for precise staging in malignant melanomaNew York (2020) 37 SeitenOnline Volltext: dx.doi.org/ Online Volltext (Open Access)
-
Ausgedehntes Rezidiv eines atypischen Fibroxanthoms
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO-Jahrestagung) 06.–09. September 2023 Hamburg, S. 99Online Volltext: dx.doi.org/ (Open Access) -
Melanom mit unbekanntem Primarius (MUP) - eine monozentrische Auswertung
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 76 - 77Online Volltext: dx.doi.org/ (Open Access) -
Role of IFNγ-induced tumor-T cell equilibrium in melanoma latencyIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 34Online Volltext: dx.doi.org/ (Open Access)
-
Therapieansprechen auf Sunitinib bei Imatinib-resistentem Rezidiv eines Dermatofibrosarkoma protuberans am Capillitium
33. Deutscher Hautkrebskongress (ADO-Jahrestagung) ; 06.–09. September 2023, Hamburg, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 21 (2023) Nr. S4, Special Issue: Abstractband anlässlich des 33. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 06.–09. September 2023 Hamburg, S. 99 - 100Online Volltext: dx.doi.org/ (Open Access) -
Tumor PD-L1 predicts the outcome of PD-1-based immunotherapy in metastatic melanoma depending on the type of tissue examined
ESMO Congress 2023 ; 20 - 24 October 2023, Madrid, Spain,In: Annals of Oncology Jg. 34 (2023) Nr. Supplement 2: Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023, S. S695Online Volltext: dx.doi.org/ -
Genetic and methylation analysis of CTNNB1 mutations in benign and malignant melanocytic lesions
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 84Online Volltext: dx.doi.org/ -
Molekularpathologie und Methylierungsprofile als diagnostische Unterstützung zur Differenzierung von Klarzellsarkomen und melanozytären Tumoren
32. Deutscher Hautkrebskongress (ADO-Jahrestagung), 14.–17. September 2022, Hannover, Germany,In: Journal der Deutschen Dermatologischen Gesellschaft (JDDG) Jg. 20 (2022) Nr. S3, S. 88Online Volltext: dx.doi.org/ -
3D data related to : Identification and quantification of hidden melanoma metastases in human sentinel lymph nodes using light sheet fluorescence microscopy(2020)